4.6 Article

A global scientific strategy to cure hepatitis B

Journal

LANCET GASTROENTEROLOGY & HEPATOLOGY
Volume 4, Issue 7, Pages 545-558

Publisher

ELSEVIER INC
DOI: 10.1016/S2468-1253(19)30119-0

Keywords

-

Funding

  1. Australian Academy of Science
  2. France Recherche (ANRS)
  3. Peter Doherty Institute for Infection and Immunity
  4. NIDDK, NIH
  5. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054516, ZIADK054500, ZIADK054509, ZIADK054505] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) is a coalition of experts dedicated to accelerating the discovery of a cure for chronic hepatitis B. Following extensive consultation with more than 50 scientists from across the globe, as well as key stakeholders including people affected by HBV, we have identified gaps in our current knowledge and new strategies and tools that are required to achieve HBV cure. We believe that research must focus on the discovery of interventional strategies that will permanently reduce the number of productively infected cells or permanently silence the covalently closed circular DNA in those cells, and that will stimulate HBV-specific host immune responses which mimic spontaneous resolution of HBV infection. There is also a pressing need for the establishment of repositories of standardised HBV reagents and protocols that can be accessed by all HBV researchers throughout the world. The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available